Perioperative anaphylaxis due to neuromuscular blocking agents occurred in roughly 58 per 100,000 administrations, with nearly 20% of cases associated with morbidity. Most patients recovered fully, ...
Researchers have found that the use of intermediate-acting neuromuscular blocking agents is linked with postoperative respiratory problems, according to a study reported in Anesthesiology News. The ...
The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words "paralyzing agent" on the vial caps of two neuromuscular blocking agents: ...
A new study evaluated the safety of succinylcholine alternatives for pediatric patients who require neuromuscular blockade for treatment. With dentists forced to look for alternatives to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results